TrialBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2023

Efficacy and Safety of Denosumab Biosimilar QL1206 Versus Denosumab in Patients with Bone Metastases from Solid Tumors: A Randomized Phase III Trial.

Huiping Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.